Cargando…
Long-Term Follow-up of a Case with Proprotein Convertase 1/3 Deficiency: Transient Diabetes Mellitus with Intervening Diabetic Ketoacidosis During Growth Hormone Therapy
Proprotein convertase 1/3 (PC1/3) deficiency is a very rare disease characterized by severe intractable diarrhea in the first years of life, followed by obesity and several hormonal deficiencies later. Diabetes mellitus requiring insulin treatment and diabetic ketoacidosis have not been reported in...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Galenos Publishing
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5596812/ https://www.ncbi.nlm.nih.gov/pubmed/28588004 http://dx.doi.org/10.4274/jcrpe.3986 |
_version_ | 1783263606742188032 |
---|---|
author | Gönç, E. Nazlı Özön, Alev Alikaşifoğlu, Ayfer Kandemir, Nurgün |
author_facet | Gönç, E. Nazlı Özön, Alev Alikaşifoğlu, Ayfer Kandemir, Nurgün |
author_sort | Gönç, E. Nazlı |
collection | PubMed |
description | Proprotein convertase 1/3 (PC1/3) deficiency is a very rare disease characterized by severe intractable diarrhea in the first years of life, followed by obesity and several hormonal deficiencies later. Diabetes mellitus requiring insulin treatment and diabetic ketoacidosis have not been reported in this disorder. We herein present a girl with PC1/3 deficiency who has been followed from birth to 17 years of age. She developed deficiencies of all pituitary hormones over time as well as diabetes mellitus while receiving growth hormone (GH) therapy. She was complicated with diabetic ketoacidosis during dietary management of diabetes mellitus, thus insulin treatment was initiated. Insulin requirement to regulate hyperglycemia was short-lived. Repeat oral glucose tolerance test five years later was normal. The findings of this patient show that diabetes mellitus can develop at any time during follow-up of cases with proportein convertase 1/3 deficiency especially under GH therapy. |
format | Online Article Text |
id | pubmed-5596812 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Galenos Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-55968122017-09-18 Long-Term Follow-up of a Case with Proprotein Convertase 1/3 Deficiency: Transient Diabetes Mellitus with Intervening Diabetic Ketoacidosis During Growth Hormone Therapy Gönç, E. Nazlı Özön, Alev Alikaşifoğlu, Ayfer Kandemir, Nurgün J Clin Res Pediatr Endocrinol Case Report Proprotein convertase 1/3 (PC1/3) deficiency is a very rare disease characterized by severe intractable diarrhea in the first years of life, followed by obesity and several hormonal deficiencies later. Diabetes mellitus requiring insulin treatment and diabetic ketoacidosis have not been reported in this disorder. We herein present a girl with PC1/3 deficiency who has been followed from birth to 17 years of age. She developed deficiencies of all pituitary hormones over time as well as diabetes mellitus while receiving growth hormone (GH) therapy. She was complicated with diabetic ketoacidosis during dietary management of diabetes mellitus, thus insulin treatment was initiated. Insulin requirement to regulate hyperglycemia was short-lived. Repeat oral glucose tolerance test five years later was normal. The findings of this patient show that diabetes mellitus can develop at any time during follow-up of cases with proportein convertase 1/3 deficiency especially under GH therapy. Galenos Publishing 2017-09 2017-09-01 /pmc/articles/PMC5596812/ /pubmed/28588004 http://dx.doi.org/10.4274/jcrpe.3986 Text en ©Copyright 2017 by Turkish Pediatric Endocrinology and Diabetes Society The Journal of Clinical Research in Pediatric Endocrinology published by Galenos Publishing House. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Gönç, E. Nazlı Özön, Alev Alikaşifoğlu, Ayfer Kandemir, Nurgün Long-Term Follow-up of a Case with Proprotein Convertase 1/3 Deficiency: Transient Diabetes Mellitus with Intervening Diabetic Ketoacidosis During Growth Hormone Therapy |
title | Long-Term Follow-up of a Case with Proprotein Convertase 1/3 Deficiency: Transient Diabetes Mellitus with Intervening Diabetic Ketoacidosis During Growth Hormone Therapy |
title_full | Long-Term Follow-up of a Case with Proprotein Convertase 1/3 Deficiency: Transient Diabetes Mellitus with Intervening Diabetic Ketoacidosis During Growth Hormone Therapy |
title_fullStr | Long-Term Follow-up of a Case with Proprotein Convertase 1/3 Deficiency: Transient Diabetes Mellitus with Intervening Diabetic Ketoacidosis During Growth Hormone Therapy |
title_full_unstemmed | Long-Term Follow-up of a Case with Proprotein Convertase 1/3 Deficiency: Transient Diabetes Mellitus with Intervening Diabetic Ketoacidosis During Growth Hormone Therapy |
title_short | Long-Term Follow-up of a Case with Proprotein Convertase 1/3 Deficiency: Transient Diabetes Mellitus with Intervening Diabetic Ketoacidosis During Growth Hormone Therapy |
title_sort | long-term follow-up of a case with proprotein convertase 1/3 deficiency: transient diabetes mellitus with intervening diabetic ketoacidosis during growth hormone therapy |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5596812/ https://www.ncbi.nlm.nih.gov/pubmed/28588004 http://dx.doi.org/10.4274/jcrpe.3986 |
work_keys_str_mv | AT goncenazlı longtermfollowupofacasewithproproteinconvertase13deficiencytransientdiabetesmellituswithinterveningdiabeticketoacidosisduringgrowthhormonetherapy AT ozonalev longtermfollowupofacasewithproproteinconvertase13deficiencytransientdiabetesmellituswithinterveningdiabeticketoacidosisduringgrowthhormonetherapy AT alikasifogluayfer longtermfollowupofacasewithproproteinconvertase13deficiencytransientdiabetesmellituswithinterveningdiabeticketoacidosisduringgrowthhormonetherapy AT kandemirnurgun longtermfollowupofacasewithproproteinconvertase13deficiencytransientdiabetesmellituswithinterveningdiabeticketoacidosisduringgrowthhormonetherapy |